Natural flavonoid pectolinarigenin alleviated kidney fibrosis via inhibiting the activation of TGFβ/SMAD3 and JAK2/STAT3 signaling-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Natural flavonoid pectolinarigenin alleviated kidney fibrosis via inhibiting the activation of TGFβ/SMAD3 and JAK2/STAT3 signaling

Published:2021-02 Issue: Volume:91 Page:107279
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Li Yanfen,Guo Fan,Huang Rongshuang,Ma Liang,Fu Ping

Funder

Key Research and Development Program of Sichuan Province

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference30 articles.

1. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017;Bikbov;Lancet,2020

2. Targeting the progression of chronic kidney disease;Ruiz-Ortega;Nat. Rev. Nephrol.,2020

3. Mechanisms of tubulointerstitial fibrosis;Zeisberg;J. Am. Soc. Nephrol.,2010

4. Renal fibrosis: novel insights into mechanisms and therapeutic targets;Boor;Nat. Rev. Nephrol.,2010

5. Origin of myofibroblasts and cellular events triggering fibrosis;Mack;Kidney Int.,2015

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 18β-glycyrrhetinic acid ameliorates bleomycin-induced idiopathic pulmonary fibrosis via inhibiting TGF-β1/JAK2/STAT3 signaling axis;The Journal of Steroid Biochemistry and Molecular Biology;2024-10

2. Loss of smad7 promoted the stromal-myofibroblast transition of endometrium via autophagy;2024-04-02

3. Pectolinarigenin and its derivatives: Bridging the gap between chemical properties and pharmacological applications;Pharmacological Research - Modern Chinese Medicine;2024-03

4. LncRNA LOC103694972 promotes fibrosis of NRK-49F cells by regulating STAT3-dependent Smad/CTGF pathway via targeting miR-29c-3p;BIOCELL;2024

5. Natural products in traditional Chinese medicine: molecular mechanisms and therapeutic targets of renal fibrosis and state-of-the-art drug delivery systems;Biomedicine & Pharmacotherapy;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3